Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 450 (1-2) , 403-407
- https://doi.org/10.1016/0006-8993(88)91584-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neuronsBrain Research, 1987
- No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acidNature, 1987
- “Selective” D-1 and D-2 receptor antagonists fail to differentially alter supersensitive locomotor behavior in the ratLife Sciences, 1986
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- Neuroleptic-induced catalepsy: A D2 blockade phenomenon?Pharmacology Biochemistry and Behavior, 1985
- No detectable remote lesions following massive intrastriatal injections of ibotenic acidBrain Research, 1981
- Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the ratLife Sciences, 1980
- Multiple receptors for dopamineNature, 1979
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976
- Cholinergic- and neuroleptic-induced catalepsy: Modification by lesions in the caudate-putamenNeuropharmacology, 1971